의료기기 수탁제조 시장 : 업계 동향과 세계 예측 - 용도별, 기기 클래스별, 대상 치료 영역별, 주요 지역별

MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: OVERVIEW

As per Roots Analysis, the global medical device contract manufacturing market valued at USD 78.8 billion in the current year is anticipated to grow at a CAGR of 8.2% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Application Areas

• Therapeutic Medical Devices
• Diagnostic Medical Devices
• Drug Delivery Medical Devices
• Other Devices

Device Class

• Class I
• Class II
• Class III

Target Therapeutic Area

• Cardiovascular Disorders
• CNS Disorders
• Metabolic Disorders
• Oncological Disorders
• Ophthalmic Disorders
• Orthopedic Disorders
• Pain Disorders
• Respiratory Disorders
• Others

Key Geographical Regions

• North America (US)
• Europe (Italy, Germany, France, Spain, UK, Rest of the Europe)
• Asia-Pacific (China, Japan, India)
• Rest of the World

MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GROWTH AND TRENDS

Over the past 50 years, the medical device industry has seen several notable developments, such as the introduction of minimally invasive surgical instruments and the rise of implantable devices like pacemakers. Additionally, the use of biomedical devices like prostheses has increased substantially over time owing to the fact that each year, millions of individuals undergo surgeries and implantations. Further, cardioverter defibrillators, prosthetic hips and knees, contact lenses, and cardiac pacemakers are some of the most commonly implanted medical devices, while fixation devices and artificial joints account for about 44% of all medical devices. This is indicative of the growing demand for medical devices in the healthcare domain. However, most developers lack adequate resources and the necessary expertise to manufacture medical devices and related components.

Given the rise of medical device CROs, the opportunity for CMOs with expertise in medical devices is also steadily rising. It is worth highlighting that, since 2000, more than 65 CMOs have been established. Further, the World Health Organization reports approximately 2 million unique medical devices worldwide, classified into more than 7,000 generic device categories. Notably, CMOs are known to offer significant cost-benefits, access to sophisticated / up-to-date infrastructure, large production capacities and reduction in time-to-market. As a result, the opportunity for medical device contract manufacturing service providers is steadily increasing.

MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: KEY INSIGHTS

The report delves into the current state of the medical device contract manufacturing market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Novel technologies and platforms have emerged as one of the primary factors responsible for the establishment and success of a number of small and mid-sized medical device companies.
• Owing to complexities associated with regulatory compliance and approvals, increasing manufacturing costs and varying technologies, sponsors seek a manufacturing partner that can support the entire lifecycle of the device.
• Over 275 companies worldwide have the necessary expertise and authorization to offer contract manufacturing services for various types of medical devices, including therapeutic and diagnostic products
• The market landscape is fragmented, featuring the presence of both established players and new entrants; presently, most medical device manufacturing facilities are located in the developed geographies.

• Medical device CMOs are actively engaged in aligning their operations to comply with the standards established by various global and regional regulatory bodies.
• Implants have emerged as one of the most prominent segments for which the acquisition activity is relatively higher; key value drivers behind such acquisitions include capability addition and geographical consolidation.
• In the last six years, over 9,600 trials evaluating various medical devices have been registered by different types of sponsors covering a wide range of therapeutic areas.
• Companies involved in this domain are steadily expanding their capabilities in order to enhance their respective service portfolios and comply with evolving industry benchmarks.
• Driven by a rapidly growing demand, medical device contract services market is anticipated to grow at annualized rate of over 8.2% for a variety of therapeutic areas and geographies for finished products.

• Established CMOs currently occupy a major share; in the long term, the opportunity is anticipated to be better distributed across different types of companies, device classes and application areas.

MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: KEY SEGMENTS

Therapeutic Medical Devices Segment holds the Largest Share of the Medical Device Contract Manufacturing Market

Based on the application areas, the market is segmented into therapeutic medical devices, diagnostic medical devices, drug delivery medical devices and other devices. At present, the therapeutic medical devices segment holds the maximum share of the global medical device contract manufacturing market owing to the increasing demand for therapeutic devices such as insulin pumps and infusion pumps. Further, the medical device contract manufacturing market for drug delivery devices segment is expected to show the highest market growth potential during the forecast period.

By Device Class, Class II is the Fastest Growing Segment of the Global Medical Device Contract Manufacturing Market

Based on the device class, the market is segmented into Class I, Class II and Class III. At present, the class II segment holds the maximum share of the global medical device contract manufacturing market. Further, owing to the various benefits offered by class II devices, such as ease of customization and diverse product range, the market for class II segment is expected to grow at a higher CAGR during the forecast period.

By Target Therapeutic Area, Orthopedic Disorders Segment Accounts for the Largest Share of the Global Medical Device Contract Manufacturing Market

Based on the target therapeutic area, the market is segmented into cardiovascular disorders, CNS disorders, metabolic disorders, oncological disorders, orthopedic disorders, ophthalmic disorders, pain disorders, respiratory disorders, and others. Currently, the orthopedic disorders segment captures the highest proportion of the global medical device contract manufacturing market. However, the metabolic disorders segment is expected to grow at a higher CAGR during the forecast period owing to the growing prevalence of metabolic disorders such as obesity, insulin resistance, Type 1 diabetes and hypertension.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, North America dominates the global medical device contract manufacturing market and accounts for the largest revenue share. Further, the market in Asia-Pacific is likely to grow at a higher CAGR in the coming future.

Example Players in the Medical Device Contract Manufacturing Market

• Cirtec Medical
• Creganna Medical
• DynaFlex Technologies
• Europlaz Technologies
• I-Tek Medical Technologies
• Interplex
• Keystone Solutions Group
• Modern Medical
• Oscor
• Riverside Medical Packaging
• SMC
• Synecco
• Suzhou Jenitek
• Stellartech Research
• Trelleborg Sealing Solutions

MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global medical device contract manufacturing market, focusing on key market segments, including [A] application areas, [B] device class, [C] target therapeutic area and [D] key geographical regions.
• Market Landscape: A comprehensive evaluation of the medical device contract manufacturers, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] manufacturing facilities, [D] geographical location, [E] type of device manufactured, [F] the scale of operation and [G] types of services offered.
• Regulatory Landscape for Medical Devices: A comprehensive discussion of the various guidelines established by major regulatory bodies for medical device approval across different countries. Additionally, the section includes a multi-dimensional bubble analysis, focusing on a comparison of the contemporary regulatory scenario in key geographies across the globe.
• Benchmark Analysis: A comprehensive benchmark analysis emphasizing the primary focus areas of small, mid-sized, and large companies, comparing their current capabilities within and across peer groups, and offering stakeholders insights to achieve a competitive advantage in the industry.
• Supply Chain Analysis: A detailed analysis of medical device supply chain, highlighting the role of CMOs engaged in the medical device contract manufacturing market and analysis based on services offered, such as [A] supply chain management services, [B] logistics services, [C] shipping services, and [D] warehousing services.
• Company Profiles: In-depth profiles of key players that specialize in providing services for both pre-commercial and commercial scale manufacturing of medical devices, focusing on [A] overview of the company, [B] service portfolio, [C] manufacturing facilities and [D] recent developments and an informed future outlook.
• Clinical Trial Analysis: An insightful analysis of clinical trials related to medical devices, based on several parameters, such as [A] number of registered trials, [B] current status of trials, [C] phase of development, [D] type of sponsor, [E] therapeutic area(s), [F] target disease indication(s), and [G] number of patients enrolled.
• Mergers and Acquisitions: An in-depth analysis of mergers and acquisitions undertaken in the medical device contract manufacturing market highlighting the number of companies acquired in recent years. Further, in depth-analysis of the key value drivers for these mergers and acquisitions was performed. In addition, the analysis features an ownership change matrix, providing a summary of the involvement of private and public sector entities in the market.
• SWOT Analysis: An analysis of industry affiliated trends, opportunities and challenges, which are likely to impact the evolution of antibody contract manufacturing market; it includes a Harvey ball analysis, assessing the relative impact of each SWOT parameter on industry dynamics.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Medical Devices: An Overview
  • 3.2.1. History of Medical Devices
  • 3.2.2. Classification of Medical Devices
• 3.3. Medical Device Manufacturing
  • 3.3.1. Challenges Associated with Medical Device Manufacturing
  • 3.3.2. Role of CMOs in Medical Device Manufacturing
  • 3.3.3. Role of Automation in Medical Device Manufacturing Process
• 3.4. Historical Timeline for Medical Device CMOs
• 3.5. Services Offered by Medical Device CMOs
• 3.6. Advantages Offered by Medical Device CMOs
• 3.7. Risks associated with Outsourcing to CMOs
• 3.8. Key Considerations
• 3.9. Concluding Remarks

4. REGULATORY LANDSCAPE FOR MEDICAL DEVICES

• 4.1. Chapter Overview
• 4.2. General Regulatory Guidelines for Medical Devices
• 4.3. Regulatory Landscape in North America
  • 4.3.1. The US Scenario
    • 4.3.1.1. Regulatory Authority
    • 4.3.1.2. Review / Approval Process
  • 4.3.2. The Canadian Scenario
    • 4.3.2.1. Regulatory Authority
    • 4.3.2.2. Review / Approval Process
• 4.4. Regulatory Landscape in Europe
  • 4.4.1. Overall Scenario
    • 4.4.1.1. Regulatory Authority
    • 4.4.1.2. Review / Approval Process
  • 4.4.2. Case Study: Brexit -The UK Scenario
• 4.5. Regulatory Landscape in Asia-Pacific
  • 4.5.1. The Chinese Scenario
    • 4.5.1.1. Regulatory Authority
    • 4.5.1.2. Review / Approval Process
  • 4.5.2. The Japanese Scenario
    • 4.5.2.1. Regulatory Authority
    • 4.5.2.2. Review / Approval Process
  • 4.5.3. The Australian Scenario
    • 4.5.3.1. Regulatory Authority
    • 4.5.3.2. Review / Approval Process
• 4.6. Comparison of Regional Regulatory Environment

5. MARKET OVERVIEW: THERAPEUTIC DEVICES

• 5.1. Chapter Overview
• 5.2. Medical Device CMOs Offering Services for Therapeutic Devices
  • 5.2.1. Analysis by Year of Establishment
  • 5.2.2. Analysis by Size of Employee Base
  • 5.2.3. Analysis by Location of Headquarters
  • 5.2.4. Analysis by Location of Manufacturing Facility
  • 5.2.5. Analysis by Regulatory Certifications / Accreditations
  • 5.2.6. Analysis by Production Services Offered
  • 5.2.7. Analysis by Post-production Services Offered
  • 5.2.8. Analysis by Other Services Offered
  • 5.2.9. Analysis by Device Class
  • 5.2.10. Analysis by Type of Material(s) Handled
  • 5.2.11. Analysis by Scale of Operation
  • 5.2.12. Leading Players

6. MARKET OVERVIEW: DIAGNOSTIC DEVICES

• 6.1. Chapter Overview
• 6.2. Medical Device CMOs Offering Services for Diagnostic Devices
  • 6.2.1. Analysis by Year of Establishment
  • 6.2.2. Analysis by Size of Employee Base
  • 6.2.3. Analysis by Location of Headquarters
  • 6.2.4. Analysis by Location of Manufacturing Facility
  • 6.2.5. Analysis by Regulatory Certifications / Accreditations
  • 6.2.6. Analysis by Production Services Offered
  • 6.2.7. Analysis by Post-Production Services Offered
  • 6.2.8. Analysis by Other Services Offered
  • 6.2.9. Analysis by Device Class
  • 6.2.10. Analysis by Type of Material(s) Handled
  • 6.2.11. Analysis by Scale of Operation
  • 6.2.12. Leading Players

7. MARKET OVERVIEW: DELIVERY SYSTEMS AND OTHERS

• 7.1. Chapter Overview
• 7.2. Catheters
  • 7.2.1. Medical Device CMOs Offering Services for Catheters
  • 7.2.2. Analysis by Year of Establishment
  • 7.2.3. Analysis by Size of Employee Base
  • 7.2.4. Analysis by Location of Headquarters
  • 7.2.5. Analysis by Location of Manufacturing Facility
  • 7.2.6. Analysis by Regulatory Certifications / Accreditations
  • 7.2.7. Analysis by Production Services Offered
  • 7.2.8. Analysis by Post-Production Services Offered
  • 7.2.9. Analysis by Other Services Offered
  • 7.2.10. Analysis by Device Class
  • 7.2.11. Analysis by Type of Material(s) Handled
  • 7.2.12. Analysis by Scale of Operation
  • 7.2.13. Leading Players
• 7.3. Drug Delivery Devices
  • 7.3.1. Medical Device CMOs Offering Services for Drug Delivery Devices
  • 7.3.2. Analysis by Year of Establishment
  • 7.3.3. Analysis by Size of Employee Base
  • 7.3.4. Analysis by Location of Headquarters
  • 7.3.5. Analysis by Location of Manufacturing Facility
  • 7.3.6. Analysis by Regulatory Certifications / Accreditations
  • 7.3.7. Analysis by Production Services Offered
  • 7.3.8. Analysis by Post-Production Services Offered
  • 7.3.9. Analysis by Other Services Offered
  • 7.3.10. Analysis by Device Class
  • 7.3.11. Analysis by Type of Material(s) Handled
  • 7.3.12. Analysis by Scale of Operation
  • 7.3.13. Leading Players
• 7.4. Other Devices
  • 7.4.1. Medical Device CMOs Offering Services for Other Medical Devices
  • 7.4.2. Analysis by Year of Establishment
  • 7.4.3. Analysis by Size of Employee Base
  • 7.4.4. Analysis by Location of Headquarters
  • 7.4.5. Analysis by Location of Manufacturing Facility
  • 7.4.6. Analysis by Regulatory Certifications / Accreditations
  • 7.4.7. Analysis by Production Services Offered
  • 7.4.8. Analysis by Post-Production Services Offered
  • 7.4.9. Analysis by Other Services Offered
  • 7.4.10. Analysis by Device Class
  • 7.4.11. Analysis by Type of Material(s) Handled
  • 7.4.12. Analysis by Scale of Operation

8. BENCHMARK ANALYSIS

• 8.1. Chapter Overview
• 8.2. Benchmark Analysis: Methodology
• 8.3. Region-wise Benchmark Analysis
  • 8.3.1. North America, Peer Group I
  • 8.3.2. North America, Peer Group II
  • 8.3.3. North America, Peer Group III
  • 8.3.4. North America, Peer Group IV
  • 8.3.5. North America, Peer Group V
  • 8.3.6. North America, Peer Group VI
  • 8.3.7. North America, Peer Group VII
  • 8.3.8. Europe, Peer Group VIII
  • 8.3.9. Europe, Peer Group IX
  • 8.3.10. Europe, Peer Group X
  • 8.3.11. Asia, Peer Group XI
  • 8.3.12. Asia, Peer Group XII
• 8.4. Concluding Remarks

9. SUPPLY CHAIN ANALYSIS

• 9.1. Chapter Overview
• 9.2. Overview of the Medical Device Supply Chain
• 9.3. Factors Affecting the Medical Device Supply Chain
• 9.4. Key Performance Indicators
• 9.5. Supply Chain Improvement Strategies
  • 9.5.1. Optimization of Supply Chain Capabilities
  • 9.5.2. Visible Supply Chain and Related Advantages
    • 9.5.2.1. Augmenting Supply Chain Visibility Through Digitalization
    • 9.5.2.2. Benefits of Digital Supply Chain
• 9.6. Effects of Supply Chain Optimization
• 9.7. Cost Analysis
  • 9.7.1. Production-related Costs
    • 9.7.1.1. Labor Costs
    • 9.7.1.2. Raw Materials Related Costs
    • 9.7.1.3. Regulatory Compliance
    • 9.7.1.4. Technology-related Costs
  • 9.7.2. Supply Chain-related Costs
    • 9.7.2.1. Local Presence
    • 9.7.2.2. Geopolitical Risk
    • 9.7.2.3. Logistics

10. COMPANY PROFILES

• 10.1. Chapter Overview
• 10.2. CMOs Headquartered in North America
  • 10.2.1. Cirtec Medical
    • 10.2.1.1. Company Overview
    • 10.2.1.2. Service Portfolio
    • 10.2.1.3. Manufacturing Capabilities and Facilities
      • 10.2.1.3.1. Facilities located in North America
      • 10.2.1.3.2. Facilities Located in Europe
    • 10.2.1.4. Future Outlook
  • 10.2.2. DynaFlex Technologies
    • 10.2.2.1. Company Overview
    • 10.2.2.2. Service Portfolio
    • 10.2.2.3. Manufacturing Capabilities and Facilities
    • 10.2.2.4. Future Outlook
  • 10.2.3. I-Tek Medical Technologies
    • 10.2.3.1. Company Overview
    • 10.2.3.2. Service Portfolio
    • 10.2.3.3. Manufacturing Capabilities and Facilities
    • 10.2.3.4. Future Outlook
  • 10.2.4. Keystone Solutions Group
    • 10.2.4.1. Company Overview
    • 10.2.4.2. Service portfolio
    • 10.2.4.3. Manufacturing Facilities
    • 10.2.4.4. Future Outlook
  • 10.2.5. Oscor
    • 10.2.5.1. Company Overview
    • 10.2.5.2. Service Portfolio
    • 10.2.5.3. Manufacturing Capabilities and facilities
    • 10.2.5.4. Future Outlook
  • 10.2.6. SMC
    • 10.2.6.1. Company Overview
    • 10.2.6.2. Service Portfolio
    • 10.2.6.3. Manufacturing Capabilities and facilities
      • 10.2.6.3.1. Facilities Located in North America
      • 10.2.6.3.2. Facility Located in Central America
      • 10.2.6.3.3. Facility Located in Europe
      • 10.2.6.3.4. Facility Located in Asia
    • 10.2.6.4. Future Outlook
  • 10.2.7. Stellartech Research
    • 10.2.7.1. Company Overview
    • 10.2.7.2. Service Portfolio
    • 10.2.7.3. Manufacturing Capabilities and facilities
    • 10.2.7.4. Future Outlook
• 10.3. CMOs Headquartered in Europe
  • 10.3.1. Creganna Medical
    • 10.3.1.1. Company Overview
    • 10.3.1.2. Service Portfolio
    • 10.3.1.3. Manufacturing Facilities
      • 10.3.1.3.1. Facilities Located in North America
      • 10.3.1.3.2. Facilities Located in Central America
      • 10.3.1.3.3. Facilities Located in Europe
      • 10.3.1.3.4. Facilities Located in Asia
    • 10.3.1.4. Future Outlook
  • 10.3.2. Europlaz Technologies
    • 10.3.2.1. Company Overview
    • 10.3.2.2. Service Portfolio
    • 10.3.2.3. Manufacturing facilities
    • 10.3.2.4. Future Outlook
  • 10.3.3. Riverside Medical Packaging
    • 10.3.3.1. Company Overview
    • 10.3.3.2. Service Portfolio
    • 10.3.3.3. Manufacturing Facilities
    • 10.3.3.4. Future Outlook
  • 10.3.4. Synecco
    • 10.3.4.1. Company Overview
    • 10.3.4.2. Service Portfolio
    • 10.3.4.3. Manufacturing Facilities
      • 10.3.4.3.1. Facilities Located in Europe
      • 10.3.4.3.2. Facilities Located in Asia
    • 10.3.4.4. Future Outlook
  • 10.3.5. Trelleborg Sealing Solutions
    • 10.3.5.1. Company Overview
    • 10.3.5.2. Service Portfolio
    • 10.3.5.3. Manufacturing Facilities
      • 10.3.5.3.1. Facilities Located in North America
      • 10.3.5.3.2. Facilities Located in Europe
    • 10.3.5.4. Future Outlook
• 10.4. CMOs Headquartered in Asia
  • 10.4.1. Interplex
    • 10.4.1.1. Company Overview
    • 10.4.1.2. Service Portfolio
    • 10.4.1.3. Manufacturing Facilities
      • 10.4.1.3.1. Facilities Located in North America
      • 10.4.1.3.2. Facilities Located in Europe
      • 10.4.1.3.3. Facilities Located in Asia
    • 10.4.1.4. Future Outlook
  • 10.4.2. Modern Medical
    • 10.4.2.1. Company Overview
    • 10.4.2.2. Service Portfolio
    • 10.4.2.3. Manufacturing facilities
    • 10.4.2.4. Future Outlook
  • 10.4.3. Providence Enterprise
    • 10.4.3.1. Company Overview
    • 10.4.3.2. Service Portfolio
    • 10.4.3.3. Manufacturing Facilities
    • 10.4.3.4. Future Outlook
  • 10.4.4. Suzhou JenitekJenitek
    • 10.4.4.1. Company overview
    • 10.4.4.2. Service Portfolio
    • 10.4.4.3. Manufacturing Facilities
    • 10.4.4.4. Future Outlook

11. CLINICAL TRIAL ANALYSIS

• 11.1. Chapter Overview
• 11.2. Scope and Methodology
• 11.3. Clinical Trial Analysis: Word Cloud of Trial Titles
• 11.4. Analysis of Clinical Trials
  • 11.4.1. Analysis by Trial Start Year
  • 11.4.2. Analysis by Trial Status
  • 11.4.3. Analysis by Phase of Development
  • 11.4.4. Analysis by Target Indication
  • 11.4.5. Analysis by Type of Sponsor
  • 11.4.6. Analysis by Geography
  • 11.4.7. Analysis by Trial Start Year and Geography
• 11.5. Analysis of Enrolled Patient Population
  • 11.5.1. Analysis by Trial Status
  • 11.5.2. Analysis by Phase of Development
  • 11.5.3. Analysis by Geography
• 11.6. Analysis of Focus Therapeutic Areas
  • 11.6.1. Analysis by Type of Sponsor
  • 11.6.2. Analysis by Geography
    • 11.6.2.1. North American Scenario
    • 11.6.2.2. European Scenario
    • 11.6.2.3. Asia Pacific Scenario
    • 11.6.2.4. Rest of the World Scenario
  • 11.6.3. Cardiovascular Disorders
    • 11.6.3.1. Analysis by Trial Start Year
    • 11.6.3.2. Analysis by Type of Sponsor
    • 11.6.3.3. Analysis by Geography
  • 11.6.4. Oncological Disorders
    • 11.6.4.1. Analysis by Trial Start Year
    • 11.6.4.2. Analysis by Type of Sponsor
    • 11.6.4.3. Analysis by Geography
  • 11.6.5. Central Nervous System (CNS) Disorders
    • 11.6.5.1. Analysis by Trial Start Year
    • 11.6.5.2. Analysis by Type of Sponsor
    • 11.6.5.3. Analysis by Geography
  • 11.6.6. Orthopedic Disorders
    • 11.6.6.1. Analysis by Trial Start Year
    • 11.6.6.2. Analysis by Type of Sponsor
    • 11.6.6.3. Analysis by Geography
  • 11.6.7. Respiratory Disorders
    • 11.6.7.1. Analysis by Trial Start Year
    • 11.6.7.2. Analysis by Type of Sponsor
    • 11.6.7.3. Analysis by Geography

12. MERGERS AND ACQUISITIONS

• 12.1. Chapter Overview
• 12.2. Merger and Acquisition Models
• 12.3. Medical Device Contract Manufacturing: Mergers and Acquisitions
  • 12.3.1. Analysis by Year of Mergers and Acquisitions
  • 12.3.2. Analysis by Type of Acquisition
  • 12.3.3. Most Active Acquirers: Analysis by Number of Acquisitions
  • 12.3.4. Analysis by Key Value Drivers
    • 12.3.4.1. Continent-wise distribution
    • 12.3.4.2. Intercontinental and Intracontinental Deals
    • 12.3.4.3. Country-wise distribution
  • 12.3.5. Ownership Change Matrix
  • 12.3.6. Acquisitions Made by Medical Device Companies
    • 12.3.6.1. Acquisition of Entire Company
      • 12.3.6.1.1. Analysis by Key Value Drivers
      • 12.3.6.1.2. Analysis by Key Value Drivers and Year of Acquisition
      • 12.3.6.1.3. Analysis by Type of Services Offered
      • 12.3.6.1.4. Analysis by Type of Device
      • 12.3.6.1.5. Analysis by Therapeutic Area
    • 12.3.6.2. Acquisition of Company Assets
      • 12.3.6.2.1. Analysis by Key Value Drivers
      • 12.3.6.2.2. Analysis by Key Value Drivers and Year of Acquisition
  • 12.3.7. Acquisition by Private Equity Firms
    • 12.3.7.1. Analysis by Year of Acquisition
    • 12.3.7.2. Analysis by Type of Acquisition
    • 12.3.7.3. Analysis by Type of Device
    • 12.3.7.4. Analysis by Therapeutic Area
• 12.4. Key Acquisitions: Deal Multiples
  • 12.4.1. Analysis by Revenues

13. CASE STUDY: OFFSHORING MEDICAL DEVICE CONTRACT MANUFACTURING

• 13.1. Chapter Overview
• 13.2. Emerging Markets: Definitions and Key Regions
• 13.3. Role of Emerging Markets in Industrial Manufacturing
  • 13.3.1. Contributions to the Automobile Industry
  • 13.3.2. Contributions to the Aerospace and Defense Industries
• 13.4. Medical Devices Manufacturing in Emerging Markets
  • 13.4.1. The US-Chinese Scenario
  • 13.4.2. Partnership with Companies in Emerging Markets
• 13.5. Multinational Companies Focused on Manufacturing Medical Devices in Emerging Markets
• 13.6. Business Models for Medical Device Manufacturing in Emerging Markets
  • 13.6.1. Case Studies
    • 13.6.1.1. Study A: Overview
      • 13.6.1.1.1. Value Proposition
      • 13.6.1.1.2. Value Creation
    • 13.6.1.2. Study B: Overview
      • 13.6.1.2.1. Value Proposition
      • 13.6.1.2.2. Value Creation
• 13.7. Key Challenges related to Innovation in the Medical Device Industry
  • 13.7.1. Limitations of In-House Innovation
• 13.8. Advantages of Establishing Innovation Hubs in Emerging Markets
  • 13.8.1. Challenges and Market Restraints
  • 13.8.2. Strategies to Address Existing Challenges
• 13.9. Future Perspectives

14. MARKET FORECAST

• 14.1. Chapter Overview
• 14.2. Forecast Methodology and Key Assumptions
• 14.3. Overall Medical Device Contract Manufacturing Market, till 2035
  • 14.3.1. Medical Device Contract Manufacturing Market: Distribution by Application Areas, till 2035
    • 14.3.1.1. Medical Device Contract Manufacturing Market for Therapeutic Devices, till 2035
    • 14.3.1.2. Medical Device Contract Manufacturing Market for Diagnostic Devices, till 2035
    • 14.3.1.3. Medical Device Contract Manufacturing Market for Drug Delivery Devices, till 2035
    • 14.3.1.4. Medical Device Contract Manufacturing Market for Other Devices, till 2035
  • 14.3.2. Medical Device Contract Manufacturing Market: Distribution by Device Class, till 2035
    • 14.3.2.1. Medical Device Contract Manufacturing Market: Class I Devices, till 2035
    • 14.3.2.2. Medical Device Contract Manufacturing Market: Class II Devices, till 2035
    • 14.3.2.3. Medical Device Contract Manufacturing Market: Class III Devices, till 2035
  • 14.3.3. Medical Device Contract Manufacturing Market: Leading Players, till 2035
  • 14.3.4. Medical Device Contract Manufacturing Market: Distribution by Therapeutic Areas, till 2035
    • 14.3.4.1. Medical Device Contract Manufacturing Market for Cardiovascular Disorders, till 2035
    • 14.3.4.2. Medical Device Contract Manufacturing Market for CNS Disorders, till 2035
    • 14.3.4.3. Medical Device Contract Manufacturing Market for Metabolic Disorders, till 2035
    • 14.3.4.4. Medical Device Contract Manufacturing Market for Oncological Disorders, till 2035
    • 14.3.4.5. Medical Device Contract Manufacturing Market for Orthopedic Disorders, till 2035
    • 14.3.4.6. Medical Device Contract Manufacturing Market for Ophthalmic Disorders, till 2035
    • 14.3.4.7. Medical Device Contract Manufacturing Market for Pain Disorders, till 2035
    • 14.3.4.8. Medical Device Contract Manufacturing Market for Respiratory Disorders, till 2035
    • 14.3.4.9. Medical Device Contract Manufacturing Market for Other Therapeutic Areas, till 2035
• 14.4. Medical Device Contract Manufacturing Market: Distribution by Geography, till 2035
  • 14.4.1. Medical Device Contract Manufacturing Market in North America, till 2035
    • 14.4.1.1. Medical Device Contract Manufacturing Market in the US, till 2035
    • 14.4.1.2. Medical Device Contract Manufacturing Market in Rest of North America, till 2035
    • 14.4.1.3. Medical Device Contract Manufacturing Market in North America: Class I Devices, till 2035
    • 14.4.1.4. Medical Device Contract Manufacturing Market in North America: Class II Devices, till 2035
    • 14.4.1.5. Medical Device Contract Manufacturing Market in North America: Class III Devices, till 2035
    • 14.4.1.6. Medical Device Contract Manufacturing Market in North America for Cardiovascular Disorders, till 2035
    • 14.4.1.7. Medical Device Contract Manufacturing Market in North America for CNS Disorders, till 2035
    • 14.4.1.8. Medical Device Contract Manufacturing Market in North America for Metabolic Disorders, till 2035
    • 14.4.1.9. Medical Device Contract Manufacturing Market in North America for Oncological Disorders, till 2035
    • 14.4.1.10. Medical Device Contract Manufacturing Market in North America for Orthopedic Disorders, till 2035
    • 14.4.1.11. Medical Device Contract Manufacturing Market in North America for Ophthalmic Disorders, till 2035
    • 14.4.1.12. Medical Device Contract Manufacturing Market in North America for Pain Disorders, till 2035
    • 14.4.1.13. Medical Device Contract Manufacturing Market in North America for Respiratory Disorders, till 2035
    • 14.4.1.14. Medical Device Contract Manufacturing Market for Other Therapeutic Areas in North America, till 2035
  • 14.4.2. Medical Device Contract Manufacturing Market in Europe, till 2035
    • 14.4.2.1. Medical Device Contract Manufacturing Market in Italy, till 2035
    • 14.4.2.2. Medical Device Contract Manufacturing Market in Germany, till 2035
    • 14.4.2.3. Medical Device Contract Manufacturing Market in France, till 2035
    • 14.4.2.4. Medical Device Contract Manufacturing Market in Spain, till 2035
    • 14.4.2.5. Medical Device Contract Manufacturing Market in the UK, till 2035
    • 14.4.2.6. Medical Device Contract Manufacturing Market in Rest of Europe, till 2035
    • 14.4.2.7. Medical Device Contract Manufacturing Market in Europe: Class I Devices, till 2035
    • 14.4.2.8. Medical Device Contract Manufacturing Market in Europe: Class II Devices, till 2035
    • 14.4.2.9. Medical Device Contract Manufacturing Market in Europe: Class III Devices, till 2035
    • 14.4.2.10. Medical Device Contract Manufacturing Market in Europe for Cardiovascular Disorders, till 2035
    • 14.4.2.11. Medical Device Contract Manufacturing Market in Europe for CNS Disorders, till 2035
    • 14.4.2.12. Medical Device Contract Manufacturing Market in Europe for Metabolic Disorders, till 2035
    • 14.4.2.13. Medical Device Contract Manufacturing Market in Europe for Oncological Disorders, till 2035
    • 14.4.2.14. Medical Device Contract Manufacturing Market in Europe for Orthopedic Disorders, till 2035
    • 14.4.2.15. Medical Device Contract Manufacturing Market in Europe for Ophthalmic Disorders, till 2035
    • 14.4.2.16. Medical Device Contract Manufacturing Market in Europe for Pain Disorders, till 2035
    • 14.4.2.17. Medical Device Contract Manufacturing Market in Europe for Respiratory Disorders, till 2035
    • 14.4.2.18. Medical Device Contract Manufacturing Market in Europe for Other Therapeutic Areas, till 2035
  • 14.4.3. Medical Device Contract Manufacturing Market in Asia Pacific, till 2035
    • 14.4.3.1. Medical Device Contract Manufacturing Market in China, till 2035
    • 14.4.3.2. Medical Device Contract Manufacturing Market in Japan, till 2035
    • 14.4.3.3. Medical Device Contract Manufacturing Market in India, till 2035
    • 14.4.3.4. Medical Device Contract Manufacturing Market in Rest of Asia Pacific, till 2035
    • 14.4.3.5. Medical Device Contract Manufacturing Market in Asia Pacific: Class I Devices, till 2035
    • 14.4.3.6. Medical Device Contract Manufacturing Market in Asia Pacific: Class II Devices, till 2035
    • 14.4.3.7. Medical Device Contract Manufacturing Market in Asia Pacific: Class III Devices, till 2035
    • 14.4.3.8. Medical Device Contract Manufacturing Market in Asia Pacific for Cardiovascular Disorders, till 2035
    • 14.4.3.9. Medical Device Contract Manufacturing Market in Asia Pacific for CNS Disorders, till 2035
    • 14.4.3.10. Medical Device Contract Manufacturing Market in Asia Pacific for Metabolic Disorders, till 2035
    • 14.4.3.11. Medical Device Contract Manufacturing Market in Asia Pacific for Oncological Disorders, till 2035
    • 14.4.3.12. Medical Device Contract Manufacturing Market in Asia Pacific for Orthopedic Disorders, till 2035
    • 14.4.3.13. Medical Device Contract Manufacturing Market in Asia Pacific for Ophthalmic Disorders, till 2035
    • 14.4.3.14. Medical Device Contract Manufacturing Market in Asia Pacific for Pain Disorders, till 2035
    • 14.4.3.15. Medical Device Contract Manufacturing Market in Asia Pacific for Respiratory Disorders, till 2035
    • 14.4.3.16. Medical Device Contract Manufacturing Market in Asia Pacific for Other Therapeutic Areas, till 2035
  • 14.4.4. Medical Device Contract Manufacturing Market in Rest of the World, till 2035
    • 14.4.4.1. Medical Device Contract Manufacturing Market in Rest of the World: Class I Devices, till 2035
    • 14.4.4.2. Medical Device Contract Manufacturing Market in Rest of the World: Class II Devices, till 2035
    • 14.4.4.3. Medical Device Contract Manufacturing Market in Rest of the World: Class III Devices, till 2035
    • 14.4.4.4. Medical Device Contract Manufacturing Market in Rest of the World for Cardiovascular Disorders, till 2035
    • 14.4.4.5. Medical Device Contract Manufacturing Market in Rest of the World for CNS Disorders, till 2035
    • 14.4.4.6. Medical Device Contract Manufacturing Market in Rest of the World for Metabolic Disorders, till 2035
    • 14.4.4.7. Medical Device Contract Manufacturing Market in Rest of the World for Oncological Disorders, till 2035
    • 14.4.4.8. Medical Device Contract Manufacturing Market in Rest of the World for Orthopedic Disorders, till 2035
    • 14.4.4.9. Medical Device Contract Manufacturing Market in Rest of the World for Ophthalmic Disorders, till 2035
    • 14.4.4.10. Medical Device Contract Manufacturing Market in Rest of the World for Pain Disorders, till 2035
    • 14.4.4.11. Medical Device Contract Manufacturing Market in Rest of the World for Respiratory Disorders, till 2035
    • 14.4.4.12. Medical Device Contract Manufacturing Market in Rest of the World for Other Therapeutic Areas, till 2035

15. SWOT ANALYSIS

• 15.1. Chapter Overview
• 15.2. Strengths
• 15.3. Weaknesses
• 15.4. Opportunities
• 15.5. Threats
• 15.6. Concluding Remarks

16. CONCLUSION

• 16.1. Chapter Overview
• 16.2. Key Takeaways

17. SURVEY / INTERVIEW TRANSCRIPTS

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS